Lukas D. Wartman, MD, is a Top Bone Marrow Transplant Specialist and Medical Oncologist with Siteman Cancer Center in St. Louis, Missouri
Lukas D. Wartman, MD, is a top oncologist who lends his skills and expertise to serve patients at Siteman Cancer Center in St. Louis, Missouri. He is Assistant Director of the Cancer Genomics Section at The McDonnell Genome Institute and Assistant Professor within the Division of Oncology, Section of Stem Cell Biology at the Washington University School of Medicine in St. Louis, MO (2013-present). With ten years of experience as an oncologist and researcher, his areas of clinical interest include the treatment of acute and chronic leukemia in adults, blood cancer, bone marrow transplant, lymphoblastic leukemia, myelogenous leukemia, and lymphocytic leukemia. Dr. Wartman is a leukemia survivor himself, and is, therefore, actively involved in making clinical sequencing available for cancer patients treated at the Siteman Cancer Center. Research interests include leukemogenesis, acute promeylocytic leukemia, cancer genomics, and epigenetics. For more information about Dr. Wartman, please visit https://oncology.wustl.edu/people/faculty/Wartman/Wartman_Res.html.
Lukas D. Wartman, MD, is a 2005-graduate of the Washington University School of Medicine in St. Louis, MO. His postgraduate training includes his residency in internal medicine at Barnes-Jewish Hospital (2005-2007), as well as his clinical fellowship in hematology-oncology (2007-2008) and his research fellowship in stem cell biology (2008-2011) performed at the Washington University School of Medicine in St. Louis, MO. Dr. Wartman completed his undergraduate education, i.e., his Bachelor of Science degree in Molecular Biology, at the University of Wisconsin in 1998. He attained board certification in internal medicine and medical oncology with the American Board of Internal Medicine. He is a member of the American Society of Hematology, the American Society of Clinical Oncology, and the American Society of Blood and Marrow Transplantation. For more information about Lukas D. Wartman, MD, please visit https://www.findatopdoc.com/doctor/2198551-Lukas-Wartman-Oncologist.
Lukas D. Wartman, MD, is the recipient of the Albert F. Koetter MD Distinguished Student Scholarship (1999-2003), Alpha Omega Alpha Induction (2002), McGraw-Hill and Appleton and Lange Medical Publications Student Award (2002), Lee B. & Virginia G. Harrison Memorial Scholarship (2002), The Park J. White Prize in Medical Ethics (2003), Knowlton Award for Clinical Excellence (2009), Fellows’ Award from Mayo Clinic Hematology/Oncology Review (2010), and National Institutes of Health Loan Repayment Program Award (2010-2012). As per Siteman Cancer Center’s website, “Dr. Wartman led the study that sequenced the first mouse model of human cancer (a mouse model of leukemia developed in Dr. Timothy Ley’s Laboratory). He recently started his own lab and is studying the role of loss of function mutations in Kdm6a, a histone H3K27 demethylase, in cancer pathogenesis. He also collaborates with investigators at The Genome Institute to organize a monthly Genomics Tumor Board.” For more information about Lukas D. Wartman, MD, please visit https://siteman.wustl.edu/doctor/wartman-lukas-md/.